col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Sociedad Espanola de Quimioterapia

110 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Revista Española de Quimioterapia 2025―Feb―05 Epidemiology of the COVID-19 pneumonia in a group of hospitals from Madrid -Spain during the full period of the State of Alarm- HM cohort José Barberán, María Ramos, Julio Villanueva, Paula Villarez, Mercedes Villareal, María Vivas, et al. (+13)
2 [GO] Revista Española de Quimioterapia 2024―Oct―30 Strengths and weaknesses of computerized clinical decision support systems: insights from a digital control center (C3 COVID-19) for early and personalized treatment for COVID-19 Tommaso Francesco Aiello, Christian Teijon-Lumbreras, Antonio Gallardo-Pizarro, Patricia Monzó-Gallo, Ana Martinez-Urrea, Guillermo Cuervo, et al. (+6)
3 [GO] Revista Española de Quimioterapia 2023―Dec―19 Increase in severe acute respiratory infections in children during the last phase of the COVID-19 pandemic Lorena Bermúdez-Barrezueta, Marta Brezmes Raposo, Marta Benito Gutiérrez, Miriam Gutiérrez Jimeno, Elva Rodríguez Merino, María Pino-Velázquez, et al. (+4)
4 [GO] Revista Española de Quimioterapia 2023―Nov―29 Association of nirmatrelvir/ritonavir and remdesivir as treatment for SARS-CoV-2 infection in immunocompromised patients with hematologic malignancies. Series of four cases Ana Segura Fábrega, Ignacio Pérez Catalán, Iris Gómez Alfaro, Sergio García Muñoz, Celia Roig Martí, Noelia Rodríguez Lozano, et al. (+7)
5 [GO] Revista Española de Quimioterapia 2023―Nov―26 Clinical experience in the treatment of COVID-19 with monoclonal antibodies in solid organ transplant recipients Elena Múñez-Rubio, Jorge Calderón-Parra, Andrea Gutiérrez-Villanueva, Ana Fernández-Cruz, Antonio Ramos-Martínez
6 [GO] Revista Española de Quimioterapia 2023―Nov―26 SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravir Miguel Villamarín, Oscar Len
7 [GO] Revista Española de Quimioterapia 2023―Sep―24 Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy Pablo Vidal-Cortés, Jorge Nieto del Olmo, Ana Isabel Tizón Varela, Estrella Seoane Fernández, Fernando Eiras Abalde, Jorge Blanco Chapela, et al. (+4)
8 [GO] Revista Española de Quimioterapia 2023―Jul―20 The importance of prevalence and pre-test probability on the microbiological diagnosis of SARS-CoV-2: the case of Spain in 2020 Andrés Canut-Blasco, Carmen Gómez-González, Raquel Barbero-Herranz, Ismael Barbero-Martínez, Eider Abasolo-Osinaga
9 [GO] Revista Española de Quimioterapia 2023―Jun―12 The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19 Cristina Borralleras, Javier Castrodeza Sanz, Pilar Arrazola, Carmen Cámara Hijón, José Mª Eiros, María Fernández-Prada, et al. (+8)
10 [GO] Revista Española de Quimioterapia 2023―Jun―02 Role of Hologic® Panther AptimaTM SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique? Cristina García-Salguero, Luis Vallejo, Mercedes Martínez-Rodríguez, Alberto Delgado-Iribarren, Esther Culebras
11 [GO] Revista Española de Quimioterapia 2023―May―02 Management of COVID-19 pandemic in hospital at home in two regional Spanish hospitals. what it meant, who we cared for, who died and how assistance has evolved over time David Sánchez Fabra, Tina Herrero Jordán, Alicia Alda Lozano, Victoria Duro Suárez, Nuria Saura Blasco, Isabel Torres Courchoud
12 [GO] Revista Española de Quimioterapia 2023―Apr―27 Pulmonary nocardiosis after covid-19 infection: case report and literature review José Ortiz, Francisco Jover, Victoria Ortiz de la Tabla, Elisabet Delgado
13 [GO] Revista Española de Quimioterapia 2023―Apr―24 Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies Francisco Javier Candel, Miguel Salavert, David Lorite Mingot, Marta Manzano Crespo, Paula Pérez Portero, Rafael Cuervo Pinto
14 [GO] Revista Española de Quimioterapia 2023―Mar―03 Response to “The importance of an early gastroenteritis diagnosis to discard MIS-C during SARS-CoV-2 pandemic” Patricia Rodríguez-Lorenzo, Marta Arias-Temprano, Alejandra , Méndez-Sánchez, Carlos Pérez-Méndez
15 [GO] Revista Española de Quimioterapia 2023―Feb―21 Impact of the COVID-19 pandemic on the mental health of the general population and health care workers Emilio Bouza, Celso Arango, Carmen Moreno, Diego Gracia, Manuel Martín, Víctor Pérez, et al. (+8)
16 [GO] Revista Española de Quimioterapia 2023―Jan―27 Epidemiological study on the impact of influenza vaccination on the clinical course of patients with COVID-19 and co-infection by both viruses in Gran Canaria, Spain José Luis Alonso Bilbao, Alejandro de Arriba Fernández, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
17 [GO] Revista Española de Quimioterapia 2023―Jan―17 Evolución temporal de las variantes de SARS-CoV-2 circulantes en el área sanitaria de Cádiz Cristina Ibañez-López, Paula Panés-Ortega, Jesús Machuca, Manuel Rodríguez-Iglesias
18 [GO] Revista Española de Quimioterapia 2022―Dec―12 Insights for COVID-19 in 2023 Francisco Javier Martín-Sánchez, Manuel Martínez-Sellés, José María Molero García, Santiago Moreno Guillén, Fernando Rodríguez-Artalejo, Julián Ruiz-Galiana, et al. (+9)
19 [GO] Revista Española de Quimioterapia 2022―Nov―21 Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital María Jesús Pérez-Granda, Pilar Catalán, Patricia Muñoz, Teresa Aldámiz, Juan Camilo Barrios, Carlos Ramírez, et al. (+4)
20 [GO] Revista Española de Quimioterapia 2022―Nov―07 Impact and control of the COVID pandemic in an elite sports club: Real Madrid Niko Mihic, Jaime Abascal, José López Chicharro, Felipe Segura, Suzanne Huurman, Borja Núñez de Aysa, Emilio Bouza
21 [GO] Revista Española de Quimioterapia 2022―Nov―02 Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper Emilio Bouza, Miguel Martin, José Enrique Alés, Nuria Aragonés, Begoña Barragán, Rafael de la Cámara, et al. (+17)
22 [GO] Revista Española de Quimioterapia 2022―Oct―24 COVID-19 in donation and transplant Francisco Javier Candel, Cándido Pardo Rey, Juan Ignacio Torres-González, Paula Fernández-Vega, Marcos Fragiel, David Oteo, et al. (+9)
23 [GO] Revista Española de Quimioterapia 2022―Oct―24 Management of hyperinflammation in COVID-19 patients Borja Suberviola, Elena Cuenca Fito
24 [GO] Revista Española de Quimioterapia 2022―Oct―24 Patients with immunization against SARS-CoV-2 who have required hospital admission due to covid-19 pneumonia in a regional hospital (Sierrallana-Cantabria) Paula Hernández Martínez, Paula González Bores, Sonia López Garrido, Lucía Paz Fajardo, Andrea Tejero Fernández, María Ezquerra Marigómez, et al. (+2)
25 [GO] Revista Española de Quimioterapia 2022―Oct―24 Antiviral drugs against SARS-CoV-2 Tommaso Francesco Aiello, Carolina García-Vidal, Alex Soriano
26 [GO] Revista Española de Quimioterapia 2022―Oct―24 Neutralizing antibodies for SARS-CoV-2 infection Juan Berenguer
27 [GO] Revista Española de Quimioterapia 2022―Oct―24 Vulnerability to SARS-CoV-2 infection and disease: ripping the curl after the storm Pablo Barreiro, Jesús San Román
28 [GO] Revista Española de Quimioterapia 2022―Oct―17 Nirmatrelvir/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patients Ignacio Pérez Catalán, Sergio García Muñoz, Celia Roig Martí, Iris Gómez Alfaro, Luis Serrano Picazo, Miguel Torres García, et al. (+5)
29 [GO] Revista Española de Quimioterapia 2022―Sep―27 Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-2 Sara Medrano, Mercedes Martínez-Rodríguez, Luis Vallejo, Esther Culebras, Alberto Delgado-Iribarren
30 [GO] Revista Española de Quimioterapia 2022―Sep―15 Impact of COVID-19 on late HIV diagnosis: a case report Alejandra Romano Cardozo, Luis Sainz Comas, Montserrat Seres Roig, Aitor Alquézar-Arbé
31 [GO] Revista Española de Quimioterapia 2022―Jul―22 Impact of Staphylococcus aureus bacteremia in COVID-19 patients Maria Espinosa Perez, Rosa García Fenoll, Saray Mormeneo Bayo, Rosa María Martínez Álvarez, Violeta Frutos Millán, María Cruz Villuendas Usón, et al. (+4)
32 [GO] Revista Española de Quimioterapia 2022―Jun―27 Lessons from COVID-19 for future disasters: an opinion paper Juan González del Castillo, Mari Cruz Martín-Delgado, Francisco Javier Martín-Sánchez, Manuel Martínez-Sellés, José María Molero García, Santiago Moreno Guillén, et al. (+9)
33 [GO] Revista Española de Quimioterapia 2022―Jun―20 Comparison between five PCR techniques for the diagnosis of SARS-CoV-2 Alberto Tenorio-Abreu, Ana Ruiz-Castillo, Antonio Francisco Guzmán-González, Alejandro Peña-Monje, José María Saavedra-Martín, Francisco Franco-Álvarez De Luna
34 [GO] Revista Española de Quimioterapia 2022―Jun―09 Impact of one year of pandemic on Spanish Intensive Care Units Pablo Vidal-Cortés, María Cruz Martín, Emili Díaz, María Bodí, José Carlos Igeño, José Garnacho-Montero
35 [GO] Revista Española de Quimioterapia 2022―May―30 The importance of an early gastroenteritis diagnosis to discard MIS-C during SARS-CoV-2 pandemic María Fernández Miaja, Ana Vivanco Allende, Sara Delgado-Nicolás, M. Eugenia Llaneza-Velasco, Javier Fernández Domínguez
36 [GO] Revista Española de Quimioterapia 2022―Apr―30 Immune treatment in COVID-19 Rosario Menéndez, Paula González, Ana Latorre, Raúl Méndez
37 [GO] Revista Española de Quimioterapia 2022―Apr―30 Respiratory consequences after COVID-19: outcome and treatment María Molina-Molina, Marta Hernández-Argudo
38 [GO] Revista Española de Quimioterapia 2022―Apr―30 Respiratory infections in Coronavirus disease 2019 Jose L. del Pozo
39 [GO] Revista Española de Quimioterapia 2022―Apr―30 Ventilation support in SARS-CoV-2 pneumonia. Strategy and indications Federico Gordo, Laura Parro, Mohamed Mohamed
40 [GO] Revista Española de Quimioterapia 2022―Apr―21 COVID-19: Some unresolved issues Javier Gómez-Pavón, Juan González del Castillo, Mari Cruz Martín-Delgado, Francisco Javier Martín-Sánchez, Manuel Martínez-Sellés, José María Molero García, et al. (+9)
41 [GO] Revista Española de Quimioterapia 2022―Apr―10 High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures Pilar Escribano, María Jesús Pérez-Granda, Roberto Alonso, Pilar Catalán, Luis Alcalá, José Antonio Serra-Rexarch, et al. (+7)
42 [GO] Revista Española de Quimioterapia 2022―Mar―09 Retrospective observational study of the persistence of SARS-CoV-2 infection in patients previously treated with rituximab María Teresa Gómez Lluch, Beatriz Proy Vega, Martín Cabero Becerra, Álvaro Rodríguez, Alberto Escalera Zalvide, Simón Ángel Sánchez
43 [GO] Revista Española de Quimioterapia 2022―Mar―06 Secondary Bordetella hinzii pneumonia in a patient with SARS-CoV-2 infection María Nieves Carmona Tello, Tomás Tosco Núñez, Irene Josefina Sainz de Aja Curbelo, Fernando Cañas Hernández
44 [GO] Revista Española de Quimioterapia 2022―Mar―04 Neisseria meningitidis bacteraemia and SARS-CoV-2 infection: a coinfection that reminds previous epidemic outbreaks Miguel Martín-Romero, David Clavero-Martínez, Antonia María Castillo-Navarro, Elisa García-Vázquez
45 [GO] Revista Española de Quimioterapia 2022―Feb―20 Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination Jordi Reina, Carla Iglesias
46 [GO] Revista Española de Quimioterapia 2022―Jan―17 Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León Carlos Avellaneda Martínez, Julio César Santos Pastor, Isabel María Marcos Sánchez, Ainhoa Narros Giménez, María Gutiérrez de Antón, Pablo Alonso Chacón
47 [GO] Revista Española de Quimioterapia 2022―Jan―05 Impact of SARS-COV-2 on the diagnosis of community bacteremia in a tertiary hospital Saray Mormeneo Bayo, Miguel Moreno Hijazo, María Pilar Palacián Ruíz,, María Cruz Villuendas Usón
48 [GO] Revista Española de Quimioterapia 2021―Dec―26 Performance of the Procleix SARS-CoV-2 transcriptase-mediated amplification (TMA) assay for the diagnosis of COVID-19 in nasopharyngeal sample pools. Small pilot study. Marta Pérez-Abeledo, Belén Ramos, Francisco Javier Candel, Juan Carlos Sanz
49 [GO] Revista Española de Quimioterapia 2021―Dec―15 Putative Secondary Structure at 5’UTR as a Potential Antiviral Target against SARS-CoV-2 Emilio Garcia-Moran, Marta Hernández, David Abad, José M. Eiros
50 [GO] Revista Española de Quimioterapia 2021―Dec―11 Pharmacological treatment of COVID-19: an opinion paper Alberto García-Lledó, Javier Gómez-Pavón, Juan González del Castillo, Teresa Hernández-Sampelayo, Mari Cruz Martín-Delgado, Francisco Javier Martín Sánchez, et al. (+9)
51 [GO] Revista Española de Quimioterapia 2021―Dec―10 Comorbidities of Primary Care patients with COVID-19 during the first wave of the SARS-CoV-2 pandemic in the Community of Madrid José-Luis Puerta, Macarena Torrego-Ellacuría, Ángel Del Rey-Mejías, César Biénzobas López
52 [GO] Revista Española de Quimioterapia 2021―Nov―26 Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment María Ema Molas, Hernando Knobel, Olivia Ferrández, Marta de Antonio Cuscó, Nuria Carballo Martínez, Cristina Rodríguez Caba, et al. (+4)
53 [GO] Revista Española de Quimioterapia 2021―Nov―19 SARS-CoV-2 infection presenting as acute acalculous cholecystitis Fernando Berdugo Hurtado, Emilio Guirao Arrabal, Andrés Barrientos Delgado, Antonio José Ruiz Rodríguez
54 [GO] Revista Española de Quimioterapia 2021―Nov―15 Booster or additional vaccination doses in patients vaccinated against COVID-19 Alejandra García-Botella, Alberto García-Lledó, Javier Gómez-Pavón, Juan González del Castillo, Teresa Hernández-Sampelayo, Mari Cruz Martín-Delgado, et al. (+9)
55 [GO] Revista Española de Quimioterapia 2021―Nov―10 Fatal sepsis months after bladder instillations with Mycobacterium bovis in patient with SARS-CoV-2 infection Pedro Manuel García-Ceberino, Emilio Guirao-Arrabal, Francisco Ferrer Amate, José Hernández-Quero
56 [GO] Revista Española de Quimioterapia 2021―Oct―29 Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications Juan González del Castillo, Agustín Julián Jiménez, Francisco Javier Candel Juan González del Castillo, Agustín Julián-Jiménez, Francisco Javier Candel
57 [GO] Revista Española de Quimioterapia 2021―Oct―21 Actions and attitudes on the immunized patients against SARS-CoV-2 Pilar De Lucas Ramos, Alejandra García-Botella, Alberto García-Lledó, Javier Gómez-Pavón, Juan González del Castillo, Teresa Hernández-Sampelayo, et al. (+9)
58 [GO] Revista Española de Quimioterapia 2021―Oct―18 Persistence and viability of SARS-CoV-2 in primary infection and reinfections Julián Ruiz-Galiana, Pilar De Lucas Ramos, Alejandra García-Botella, Alberto García-Lledó, Javier Gómez-Pavón, Juan González del Castillo, et al. (+9)
59 [GO] Revista Española de Quimioterapia 2021―Oct―08 Increased severity in SARS-CoV-2 infection of minorities in Spain Adrián Valls Carbó, Juan González del Castillo, Oscar Miró, Pedro Lopez-Ayala, Sonia Jimenez, Javier Jacob, et al. (+2)
60 [GO] Revista Española de Quimioterapia 2021―Oct―07 Primer caso de reinfección confirmada por SARS-CoV-2 en el área sur de Gran Canaria María Aroca-Ferri, Tomás Tosco-Núñez, Araceli Hernández-Betancor, Isabel de-Miguel-Martínez
61 [GO] Revista Española de Quimioterapia 2021―Oct―02 Vaccination strategies against SARS-CoV-2: General impact on the development of the pandemic Ángel Gil de Miguel, Ruth Gil-Prieto
62 [GO] Revista Española de Quimioterapia 2021―Oct―02 Role of molecular diagnostics in the clinical management of SARS-CoV-2 infection: advantages and drawbacks Carmen Martín-Higuera, Irene Muñoz-Gallego, María Dolores Folgueira
63 [GO] Revista Española de Quimioterapia 2021―Oct―02 Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control Rafael Delgado
64 [GO] Revista Española de Quimioterapia 2021―Oct―02 Ventilatory support and corticosteroid therapy in SARS-CoV-2 Fernando Martínez Sagasti, Alba Palazón Blanco, Sandra Catalina García-Perrote, Patricia Alonso Martínez
65 [GO] Revista Española de Quimioterapia 2021―Oct―02 COVID-19: Impact on prescribing and antimicrobial resistance Patricia Ruiz-Garbajosa, Rafael Cantón
66 [GO] Revista Española de Quimioterapia 2021―Oct―02 Approach to COVID-19 pandemic management in Madrid. Chronic of a year Francisco Javier Candel, Pablo Barreiro, Jesús San-Román, Juan Carlos Sanz-Moreno, María del Mar Carretero, Francisco Javier Martínez-Peromingo, et al. (+6)
67 [GO] Revista Española de Quimioterapia 2021―Oct―02 COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications Mariana Chumbita, Pedro Puerta-Alcalde, Nicole Garcia-Pouton, Carolina García-Vidal
68 [GO] Revista Española de Quimioterapia 2021―Oct―02 Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19 Pablo Barreiro, Jesús San-Román, María del Mar Carretero, Francisco Javier Candel
69 [GO] Revista Española de Quimioterapia 2021―Oct―02 Antiviral therapy and immunotherapy of COVID-19 Clara Crespillo, Santiago Moreno
70 [GO] Revista Española de Quimioterapia 2021―Oct―02 Respiratory co-and superinfections in COVID-19 José L del Pozo
71 [GO] Revista Española de Quimioterapia 2021―Oct―01 What happened to microbiological diagnosis in 2020 beyond COVID-19? Emilia Cercenado
72 [GO] Revista Española de Quimioterapia 2021―Oct―01 What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19? Saray Mormeneo Bayo, Juan M. García-Lechuz Moya
73 [GO] Revista Española de Quimioterapia 2021―Sep―29 Mycophenolate as a corticoid saver in a patient with pneumonia organized by COVID-19 María José Esteve Gimeno, Celia Roig Martí, Ignacio Pérez Catalán, Núria Tornador Gaya, Jorge Usó Blasco
74 [GO] Revista Española de Quimioterapia 2021―Sep―22 Evaluation of the validity of Ag PANBIO-COVID19 in the diagnosis of SARS-CoV-2 infection in asymptomatic or mildly infected patients Paula Gras-Valenti, Inmaculada Vidal, Inés Montiel-Higuero, Isabel Escribano, Natividad Algado-Selles, Pablo Chico-Sánchez, et al. (+6)
75 [GO] Revista Española de Quimioterapia 2021―Sep―17 Oral antibiotic treatment of exacerbation of COPD. Beyond COVID-19 José Miguel Rodríguez González-Moro, José Luis Izquierdo Alonso
76 [GO] Revista Española de Quimioterapia 2021―Jul―28 Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19 José Barberán, Lourdes Cristina Barberán, Alicia de la Cuerda
77 [GO] Revista Española de Quimioterapia 2021―Jul―21 Vaccine against COVID-19 Juan Picazo
78 [GO] Revista Española de Quimioterapia 2021―Jul―16 Pneumonia in patients with SARS-CoV-2 infection: series of 17 cases in the region of Murcia Encarnación Moral Escudero, Alicia Hernández Torres, Aychel Elena Roura Piloto, Helena Albendín Iglesias, Ana Peláez Ballesta, Elisa García Vázquez
79 [GO] Revista Española de Quimioterapia 2021―Jun―02 New variants of SARS-CoV-2 Rafael Cantón, Pilar De Lucas Ramos, Alejandra García-Botella, Alberto García-Lledó, Javier Gómez-Pavón, Juan González del Castillo, et al. (+9)
80 [GO] Revista Española de Quimioterapia 2021―May―31 Prognostic value of static and dynamic biomarkers in COVID-19 patients: a prospective cohort study Macarena Hormanstorfer, Héctor Borodowski, Kevin Nelson, María Jazmín Patrosso, Ingrid Kolland, Luca Italiano, et al. (+11)
81 [GO] Revista Española de Quimioterapia 2021―May―19 Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort Pablo Cardinal-Fernández, Esteban Garcia Cuesta, José Barberán, José F. Varona, Alberto Estirado, Alberto Moreno, et al. (+15)
82 [GO] Revista Española de Quimioterapia 2021―May―13 Experience with the use of siltuximab in patients with SARS-CoV-2 infection Fernanda Meira, Laia Albiach, Cristina Carbonell, José-Ángel Martín-Oterino, Mercedes Martín-Ordiales, Laura Linares, et al. (+29)
83 [GO] Revista Española de Quimioterapia 2021―Apr―29 Comparative study of the COVID-19 admissions between first and second wave in a cohort of 1,235 patients Pilar López-Juárez, Leticia Serrano-Oviedo, José Manuel Pérez-Ortiz, Inmaculada García-Jabalera, Natalia Bejarano-Ramírez, Francisco Javier Gómez-Romero, et al. (+2)
84 [GO] Revista Española de Quimioterapia 2021―Apr―28 COVID-19 vaccination: the reality after clinical trials Julián Ruiz-Galiana, Rafael Cantón, Pilar De Lucas Ramos, Alejandra García-Botella, Alberto García-Lledó, Javier Gómez-Pavón, et al. (+9)
85 [GO] Revista Española de Quimioterapia 2021―Apr―27 Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2 Jordi Reina
86 [GO] Revista Española de Quimioterapia 2021―Apr―23 Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses Jordi Reina, Ricardo M. Arcay, María Busquets, Herminia Machado
87 [GO] Revista Española de Quimioterapia 2021―Apr―07 Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection Estela Moreno-García, Verónica Rico, Laia Albiach, Daiana Agüero, Juan Ambrosioni, Marta Bodro, et al. (+34)
88 [GO] Revista Española de Quimioterapia 2021―Apr―07 Evolution of adherence to hand hygiene in health care professionals in a third level hospital in relation to the SARS-CoV-2 pandemic Alejandro de Arriba-Fernández, Manuel Jesús Molina-Cabrillana, Lluís Serra Majem
89 [GO] Revista Española de Quimioterapia 2021―Mar―23 Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter? Alejandro Suarez-de-la-Rica, Patricia Serrano, Rodrigo de-la-Oliva, Pedro Sánchez-Díaz, Pilar Molinero, Iker Falces-Romero, et al. (+3)
90 [GO] Revista Española de Quimioterapia 2021―Mar―23 Temporary hospitals in times of the COVID pandemic. An example and a practical view Francisco Javier Candel, Jesús Canora, Antonio Zapatero, Raquel Barba, Juan González del Castillo, Gonzalo García-Casasola, et al. (+8)
91 [GO] Revista Española de Quimioterapia 2021―Mar―22 Current microbiological aspects of community respiratory infection beyond COVID-19 Rafael Cantón
92 [GO] Revista Española de Quimioterapia 2021―Mar―06 Real-life use of remdesivir in hospitalized patients with COVID-19 Carolina Garcia-Vidal, Fernanda Meira, Alberto Cózar-Llistó, Gerard Dueñas, Pedro Puerta-Alcalde, Nicole Garcia-Pouton, et al. (+19)
93 [GO] Revista Española de Quimioterapia 2021―Feb―01 Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients Sara Ortonobes Roig, Nuria Soler-Blanco, Isabel Torrente Jiménez, Eva Van den Eynde Otero, Marc Moreno-Ariño, Mònica Gómez-Valent
94 [GO] Revista Española de Quimioterapia 2020―Dec―15 COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome Pablo Vidal-Cortés, Lorena del Río-Carbajo, Jorge Nieto-del Olmo, Estefanía Prol-Silva, Ana I. Tizón-Varela, Ana Rodríguez-Vázquez, et al. (+4)
95 [GO] Revista Española de Quimioterapia 2020―Nov―24 Use of the SARS-CoV-2 antigen detection test in nasopharyngeal swab for COVID-19 infection control M. Dolores Folgueira López
96 [GO] Revista Española de Quimioterapia 2020―Oct―19 Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings Francisco Javier Candel, Pablo Barreiro, Jesús San Román, Juan Carlos Abanades, Raquel Barba, José Barberán, et al. (+21)
97 [GO] Revista Española de Quimioterapia 2020―Sep―22 Description of Influenza B in seasonal epidemic in Cantabria during the beginning of the pandemia due to SARS-CoV-2 Daniel Pablo-Marcos, Ana Rodríguez-Fernández, Mónica Gozalo, Jesús Agüero, Francisco Arnaiz de Las Revillas, Jorge Calvo
98 [GO] Revista Española de Quimioterapia 2020―Sep―18 SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study Maria Carmen Viñuela, Juan Antonio De León-Luis, Roberto Alonso, Pilar Catalán, Santiago Lizarraga, Patricia Muñoz, Emilio Bouza
99 [GO] Revista Española de Quimioterapia 2020―Sep―11 Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability Javier Pardo Lledias, Laura Ayarza, Pablo González-García, Zaida Salmón González, Jorge Calvo Montes, Mónica Gozalo Marguello, et al. (+2)
100 [GO] Revista Española de Quimioterapia 2020―Sep―11 Immunity against SARS-CoV-2: walking to the vaccination Carmen Rodríguez Hernández, Juan Carlos Sanz Moreno
101 [GO] Revista Española de Quimioterapia 2020―Aug―03 Differential diagnosis of pneumonia at the time of COVID-19 Marcos Fragiel, Jesús Canora Lebrato, Francisco Javier Candel, Antonio Zapatero Gaviria, Javier Marco Martínez, Juan González del Castillo
102 [GO] Revista Española de Quimioterapia 2020―Jul―30 The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up Patricia Muñoz, Alicia Galar, Pilar Catalán, Maricela Valerio, Teresa Aldamiz-Echevarría, Carlos Cólliga, Emilio Bouza
103 [GO] Revista Española de Quimioterapia 2020―Jul―20 Scoping review of coronavirus case series (SARS-CoV, MERS-CoV and SARS-CoV-2) and their obstetric and neonatal results Noelia Rodríguez-Blanco, Irene Vegara-Lopez, Loreto Aleo-Giner, José Tuells
104 [GO] Revista Española de Quimioterapia 2020―Jul―13 Potential biomarkers predictors of mortality in COVID-19 patients in the Emergency Department Natalia F. Pascual Gómez, Iván Monge Lobo, Inmaculada Granero Cremades, Angels Figuerola Tejerina, Fernando Ramasco Rueda, Andrés von Wernitz Teleki, et al. (+2)
105 [GO] Revista Española de Quimioterapia 2020―Jun―25 Baricitinib in the treatment of SARS-CoV-2 infection Marta Gutiérrez-Lorenzo, Carmen María Cuadros-Martínez
106 [GO] Revista Española de Quimioterapia 2020―Jun―10 Impact of Spanish Public Health Measures on Emergency Visits and COVID- 19 diagnosed cases during the pandemic in Madrid Francisco Javier Martín-Sánchez, Adrián Valls Carbó, Amanda López Picado, Carmen Martínez-Valero, Juande D. Miranda, José María Leal Pozuleo, Juan González del Castillo
107 [GO] Revista Española de Quimioterapia 2020―Jun―04 Utility of lateral flow tests in SARS-CoV-2 infection monitorization Francisco Javier Candel González, José Manuel Viñuela-Prieto, Juan González del Castillo, Pablo Barreiro García, Marcos Fragiel Saavedra, Alba Hernández Píriz, et al. (+10)
108 [GO] Revista Española de Quimioterapia 2020―May―27 Evaluation of different genes in the RT-PCR detection of SARS-CoV-2 in respiratory samples and its evolution in infection Jordi Reina, Loreto Suarez
109 [GO] Revista Española de Quimioterapia 2020―May―21 COVID-19 in Spanish and immigrant patients in a sanitary district of Madrid Jerónimo Jaqueti Aroca, Laura M. Molina Esteban, Isabel García-Arata, Jesús García-Martínez
110 [GO] Revista Española de Quimioterapia 2020―Apr―01 Remdesivir, the antiviral hope against SARS-CoV-2 Jordi Reina
 [1] 

110 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec